Clover Health Investments (CLOV)
(Delayed Data from NSDQ)
$4.20 USD
+0.08 (1.94%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $4.20 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth F Momentum B VGM
View All Zacks #1 Ranked Stocks
Clover Health Investments, Corp. (CLOV) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
|---|---|---|---|
| $2.07 | $3.20 | $1.00 | -49.76% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Clover Health Investments, Corp. comes to $2.07. The forecasts range from a low of $1.00 to a high of $3.20. The average price target represents a decline of 49.76% from the last closing price of $4.12.
Analyst Price Targets (3 )
Broker Rating
Clover Health Investments, Corp. currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 2.33 a month ago based on three recommendations.
Of the three recommendations deriving the current ABR, one is Strong Buy, representing 33.33% of all recommendations. A month ago, Strong Buy represented 33.33%.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 2.33 | 2.33 | 2.33 | 2.33 | 2.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 8/5/2024 | Canaccord Genuity | Richard Close | Strong Buy | Strong Buy |
| 6/3/2024 | Not Identified | Not Identified | Hold | Hold |
| 3/1/2024 | SVB Securities | Whit Mayo | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 2.33 |
| ABR (Last week) | 2.33 |
| # of Recs in ABR | 3 |
| Average Target Price | $2.07 |
| LT Growth Rate | NA |
| Industry | Medical Info Systems |
| Industry Rank by ABR | 74 of 252 |
| Current Quarter EPS Est: | -0.03 |
CLOV FAQs
Clover Health Investments, Corp. (CLOV) currently has an average brokerage recommendation (ABR) of 2.33 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for Clover Health Investments, Corp. (CLOV) is $2.07. The current on short-term price targets is based on 1 reports.
The forecasts for Clover Health Investments, Corp. (CLOV) range from a low of $1 to a high of $3.2. The average price target represents a decline of $50.71 from the last closing price of $4.20.
The current DOWNSIDE for Clover Health Investments, Corp. (CLOV) is 50.71%
Based on short-term price targets offered by three analysts, the average price target for Clover Health Investments, Corp. comes to $2.07. The forecasts range from a low of $1.00 to a high of $3.20. The average price target represents a decline of 49.76% from the last closing price of $4.12.